RYBELSUS® (semaglutide) tablets 7 mg or 14 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
This is an educational tool that recounts the highlights of RYBELSUS®. This piece covers the efficacy and safety data for RYBELSUS® from clinical trials, Important Safety Information, administration and dosing.
US19RYB00384
RYBELSUS® (semaglutide) tablets 7 mg or 14 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
WARNING: RISK OF THYROID C-CELL TUMORS